KINGFAKingfa Science & Technology (India) Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Kingfa Science & Technology (India) Limited manufactures and supplies reinforced polypropylene compounds, thermoplastics elastomers, and personal protective equipment masks and gloves in India. It also offers engineering plastics including ABS, HIPS, PA, PBT, PC and their alloys; biodegradable nitrile gloves and protective coverall; thermoplastic elastomers under the HYPRENE brand name; POM and LFT products; fiberglass honeycomb composite panels; polypropylene products; PA6/PA66 products; engineering plastics compounds; and high temperature resistant nylon/LCP. The company was formerly known as Hydro S&S Industries Limited and changed its name to Kingfa Science & Technology (India) Limited in March 2016. The company was incorporated in 1983 and is based in Pune, India. Kingfa Science & Technology (India) Limited is a subsidiary of M/s Kingfa Science & Technology Co. Ltd China.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on KINGFA — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why buy
- • Revenue growth: 23.2% YoY
- • Profit growth: 26.2% YoY
- • ROE: 17.4%
- • RSI: 65
- • MACD: fresh bullish crossover
- • Price vs EMA21: above
Bull case
- • Revenue growth: 23.2% YoY
- • Profit growth: 26.2% YoY
- • ROE: 17.4%
- • RSI: 65
Bear case
- • Valuation vs sector: P/E 43.1 vs sector 27.1
- • Dividend yield: 0.00%
- • Volume: 0.7x 20-day average
Key risks
- • Valuation vs sector: P/E 43.1 vs sector 27.1
- • Dividend yield: 0.00%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹190.32). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.